Our aim is to become a world leader in respiratory medicine, building on our reputation for providing the NHS with quality modified release preparations. Chiesi's UK operations are focussed on driving our success by meeting the needs of health professionals and helping them to improve outcomes for patients. Our highly trained and dynamic sales teams are fully equipped to provide a valued service to our customers. Our corporate product range consists of treatments for Asthma, COPD, Cystic Fibrosis, Ulcerative Colitis, Respiratory Distress Syndrome in premature babies and Apnoea in premature new-borns.
Facts & Figures
|Number of employees||250|
|Number of active countries||60|